 |
138 Diseases |  |
93 Trials |
|
93 Trials |  |
2194 News |  |
| «12...22232425262728293031323334» |
- Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Trial initiation date: Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=32, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Initiation date: Feb 2013 --> Aug 2013
- | tamoxifen / Generic mfg.
Trial completion: Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer (clinicaltrials.gov) - Jul 31, 2013
P3, N=6000, Completed, Sponsor: Institute of Cancer Research, United Kingdom
Initiation date: Feb 2013 --> Aug 2013 Active, not recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment change: GnRH-a and Pregnancy Rate in In Vitro Fertilization (IVF) Cycles. (clinicaltrials.gov) - Jul 22, 2013
P=N/A, N=180, Completed, Sponsor: University of Ioannina
Active, not recruiting --> Completed N=120 --> 180
- leuprolide acetate for depot suspension / Generic mfg., pioglitazone / Generic mfg.
Trial termination: Polycystic Ovary Syndrome (PCOS) and Sleep Apnea (clinicaltrials.gov) - Jul 15, 2013
P4, N=37, Terminated, Sponsor: University of Chicago
N=120 --> 180 Completed --> Terminated; Did not meet target patient accrual goals
- leuprolide acetate for depot suspension / Generic mfg., pioglitazone / Generic mfg.
Enrollment change: Polycystic Ovary Syndrome (PCOS) and Sleep Apnea (clinicaltrials.gov) - Jul 15, 2013
P4, N=37, Terminated, Sponsor: University of Chicago
Completed --> Terminated; Did not meet target patient accrual goals N=130 --> 37
- |||| abiraterone acetate / Generic mfg.
Trial completion: Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer (clinicaltrials.gov) - Jul 1, 2013
P2, N=66, Completed, Sponsor: Cougar Biotechnology, Inc.
N=130 --> 37 Recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
Trial withdrawal: OMLET: Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients (clinicaltrials.gov) - Jun 20, 2013
P4, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Terminated --> Withdrawn
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment change: OMLET: Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients (clinicaltrials.gov) - Jun 20, 2013
P4, N=0, Withdrawn, Sponsor: Weill Medical College of Cornell University
Terminated --> Withdrawn N=224 --> 0
- | Yervoy (ipilimumab) / BMS
Enrollment closed, IO biomarker: Neoadjuvant Ipilimumab in Prostate Cancer (clinicaltrials.gov) - Jun 12, 2013
P2a, N=20, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
N=224 --> 0 Recruiting --> Active, not recruiting
- Emcyt (estramustine) / Pfizer, Nippon Shinyaku
Enrollment change, Combination therapy, Metastases: S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Jun 11, 2013
P2, N=41, Completed, Sponsor: Southwest Oncology Group
Recruiting --> Active, not recruiting N=80 --> 41
- Emcyt (estramustine) / Pfizer, Nippon Shinyaku
Trial completion, Combination therapy, Metastases: S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - Jun 11, 2013
P2, N=41, Completed, Sponsor: Southwest Oncology Group
N=80 --> 41 Active, not recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg., bicalutamide / Generic mfg.
Enrollment change: Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial (clinicaltrials.gov) - May 29, 2013
P3, N=6, Completed, Sponsor: Schiffler Cancer Center
Active, not recruiting --> Completed N=350 --> 6
- leuprolide acetate for depot suspension / Generic mfg., bicalutamide / Generic mfg.
Trial completion: Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial (clinicaltrials.gov) - May 29, 2013
P3, N=6, Completed, Sponsor: Schiffler Cancer Center
N=350 --> 6 Recruiting --> Completed
- ||||| leuprolide acetate for depot suspension / Generic mfg.
Enrollment closed: Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer (clinicaltrials.gov) - Apr 25, 2013
P3, N=160, Active, not recruiting, Sponsor: GP-Pharm
Recruiting --> Completed Recruiting --> Active, not recruiting
- | zoledronic acid / Generic mfg.
Trial completion: Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy (clinicaltrials.gov) - Apr 23, 2013
P2, N=44, Completed, Sponsor: University of Wisconsin, Madison
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- prednisone / Generic mfg., abiraterone acetate / Generic mfg.
Enrollment closed: Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer (clinicaltrials.gov) - Apr 16, 2013
P2, N=25, Active, not recruiting, Sponsor: University of Washington
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- leuprolide acetate for depot suspension / Generic mfg., docetaxel / Generic mfg.
New P3 trial: A Registry for Patients Treated on the Clinical Trial TAX 3503 (clinicaltrials.gov) - Mar 17, 2013
P3, N=19, Enrolling by invitation, Sponsor: Memorial Sloan-Kettering Cancer Center
- |||| prednisone / Generic mfg., leuprolide acetate for depot suspension / Generic mfg., abiraterone acetate / Generic mfg.
Trial completion: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer (clinicaltrials.gov) - Mar 5, 2013
P2, N=58, Completed, Sponsor: Janssen Research & Development, LLC
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || leuprolide acetate for depot suspension / Generic mfg.
Trial initiation date: Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot (clinicaltrials.gov) - Feb 21, 2013
P1, N=58, Completed, Sponsor: L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Active, not recruiting --> Completed Initiation date: Feb 2010 --> Aug 2010
- ||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot (clinicaltrials.gov) - Feb 21, 2013
P1, N=58, Completed, Sponsor: L.A.L Clinica Pesquisa e Desenvolvimento Ltda.
Initiation date: Feb 2010 --> Aug 2010 Recruiting --> Completed
- | everolimus / Generic mfg.
Trial initiation date: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (clinicaltrials.gov) - Feb 18, 2013
P3, N=3500, Recruiting, Sponsor: Southwest Oncology Group
Recruiting --> Completed Initiation date: Sep 2012 --> Apr 2013
- semaxanib (SU5416) / Pfizer
Trial completion, Metastases: SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer (clinicaltrials.gov) - Jan 31, 2013
P1, N=3, Completed, Sponsor: University of Chicago
Initiation date: Sep 2012 --> Apr 2013 Active, not recruiting --> Completed
- | letrozole / Generic mfg., leuprolide acetate for depot suspension / Generic mfg., zoledronic acid / Generic mfg.
Enrollment change: Extended Endocrine Therapy for Premenopausal Women With Breast Cancer (clinicaltrials.gov) - Jan 29, 2013
P2, N=17, Active, not recruiting, Sponsor: Dana-Farber Cancer Institute
Active, not recruiting --> Completed N=50 --> 17
- | letrozole / Generic mfg., leuprolide acetate for depot suspension / Generic mfg., zoledronic acid / Generic mfg.
Enrollment closed: Extended Endocrine Therapy for Premenopausal Women With Breast Cancer (clinicaltrials.gov) - Jan 29, 2013
P2, N=17, Active, not recruiting, Sponsor: Dana-Farber Cancer Institute
N=50 --> 17 Recruiting --> Active, not recruiting
- | leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Influence of Male Hormones on Regional Fat Metabolism (clinicaltrials.gov) - Jan 29, 2013
P=N/A, N=39, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
New P4 trial: Study of a Progestin to Prevent Bleeding Associated With Initiation of Medical Menopause With GnRH Agonist (clinicaltrials.gov) - Jan 24, 2013
P4, N=40, Recruiting, Sponsor: Malcolm G. Munro
- leuprolide acetate for depot suspension / Generic mfg.
Trial initiation date: DUALTRIGGER: Study of Dual Trigger Ovulation in Oocyte Donors (clinicaltrials.gov) - Jan 21, 2013
P4, N=180, Recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Initiation date: Jul 2012 --> Jan 2013
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment open: DUALTRIGGER: Study of Dual Trigger Ovulation in Oocyte Donors (clinicaltrials.gov) - Jan 21, 2013
P4, N=180, Recruiting, Sponsor: Weill Medical College of Cornell University
Initiation date: Jul 2012 --> Jan 2013 Not yet recruiting --> Recruiting
- ||||| opigolix (ASP1707) / Astellas
New P2 trial: A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain (clinicaltrials.gov) - Jan 10, 2013
P2, N=600, Recruiting, Sponsor: Astellas Pharma Europe BV
- ||||||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty (clinicaltrials.gov) - Jan 9, 2013
P3, N=72, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- | Trial completion: CAN-NCIC-PR7: Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer (clinicaltrials.gov) - Jan 9, 2013
P3, N=1386, Completed, Sponsor: NCIC Clinical Trials Group
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Torisel (temsirolimus) / Pfizer
Trial termination: Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer (clinicaltrials.gov) - Jan 3, 2013
P1, N=24, Terminated, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Withdrawn --> Terminated
- | Firmagon (degarelix) / Astellas, Ferring
Enrollment open: Degarelix in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Dec 19, 2012
P3, N=100, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
Withdrawn --> Terminated Not yet recruiting --> Recruiting
- docetaxel / Generic mfg.
Trial termination: Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer (clinicaltrials.gov) - Dec 16, 2012
P3, N=48, Terminated, Sponsor: NCIC Clinical Trials Group
Not yet recruiting --> Recruiting Completed --> Terminated; Poor accrual
- goserelin acetate / Generic mfg., leuprolide acetate for depot suspension / Generic mfg.
New P2 trial: Bipolar Androgen-based Therapy for Prostate Cancer (BAT) (clinicaltrials.gov) - Dec 13, 2012
P2, N=33, Active, not recruiting, Sponsor: Sidney Kimmel Comprehensive Cancer Center
- ||||| Kepivance (palifermin) / SOBI, Amgen, Firmagon (degarelix) / Astellas, Ferring
New P2 trial: Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (clinicaltrials.gov) - Dec 9, 2012
P2, N=180, Recruiting, Sponsor: Memorial Sloan-Kettering Cancer Center
- |||| leuprolide acetate for depot suspension / Generic mfg., triptorelin / Generic mfg.
Trial completion, Metastases: Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration (clinicaltrials.gov) - Dec 2, 2012
P4, N=118, Completed, Sponsor: Watson Pharmaceuticals
Completed --> Terminated; Poor accrual Active, not recruiting --> Completed
- | leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy (clinicaltrials.gov) - Nov 8, 2012
P2, N=50, Completed, Sponsor: Mayo Clinic
Active, not recruiting --> Completed Active, not recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
Trial completion: Melanoma Vaccine With Peptides and Leuprolide (clinicaltrials.gov) - Oct 29, 2012
P2, N=98, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- || Firmagon (degarelix) / Astellas, Ferring
New P3 trial: Degarelix in the Treatment of Endometriosis Recurrence (clinicaltrials.gov) - Oct 22, 2012
P3, N=100, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
- leuprorelin depot / Generic mfg.
Clinical: Females, Aging, Metabolism, and Exercise (clinicaltrials.gov) - Oct 21, 2012
P=N/A, N=132, Recruiting, Sponsor: University of Colorado, Denver
- |||| leuprolide acetate for depot suspension / Generic mfg.
Trial completion: GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients (clinicaltrials.gov) - Oct 4, 2012
P2, N=60, Completed, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Firmagon (degarelix) / Astellas, Ferring
Trial completion: A Study of Degarelix in Patients With Prostate Cancer (clinicaltrials.gov) - Sep 23, 2012
P3, N=405, Completed, Sponsor: Ferring Pharmaceuticals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | leuprolide acetate for depot suspension / Generic mfg., docetaxel / Generic mfg.
Trial completion, Metastases: Rapid Hormone Cycling With Testosterone and Leuprolide Combined With Docetaxel in Treating Patients With Recurrent or Metastatic Adenocarcinoma (Cancer) of the Prostate (clinicaltrials.gov) - Sep 12, 2012
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- docetaxel / Generic mfg.
Trial initiation date: Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer (clinicaltrials.gov) - Aug 27, 2012
P1/2, N=25, Recruiting, Sponsor: University of Kansas
Active, not recruiting --> Completed Initiation date: Sep 2008 --> Aug 2012
- docetaxel / Generic mfg.
Enrollment open: Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer (clinicaltrials.gov) - Aug 27, 2012
P1/2, N=25, Recruiting, Sponsor: University of Kansas
Initiation date: Sep 2008 --> Aug 2012 Terminated --> Recruiting
- | triptorelin / Generic mfg.
New P4 trial, Metastases: GREAT: GP Extended Action Triptorelin (clinicaltrials.gov) - Aug 26, 2012
P4, N=21, Completed, Sponsor: Ipsen
- || everolimus / Generic mfg.
New P3 trial: S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (clinicaltrials.gov) - Aug 26, 2012
P3, N=3500, Recruiting, Sponsor: Southwest Oncology Group
- pazopanib / Generic mfg.
Enrollment closed: Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer (clinicaltrials.gov) - Aug 23, 2012
P2, N=98, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Terminated --> Recruiting Completed --> Active, not recruiting
- leuprorelin depot / Generic mfg.
Clinical: Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation (clinicaltrials.gov) - Aug 19, 2012
P=N/A, N=40, Recruiting, Sponsor: Main Line Fertility Center